trending Market Intelligence /marketintelligence/en/news-insights/trending/tpieum-cuka6cp33pcnfkq2 content esgSubNav
In This List

PolarityTE adds former US FDA, Johnson & Johnson executive as director

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


PolarityTE adds former US FDA, Johnson & Johnson executive as director

PolarityTE Inc. has appointed Minnie Baylor-Henry to the board.

Previously, Baylor-Henry was a regulatory review officer, among other positions, at the U.S. Food and Drug Administration's Office of Regulatory Affairs. She was also vice president of U.S. regulatory affairs and medical affairs for specialty pharmaceuticals at Johnson & Johnson.

Salt Lake City-based PolarityTE is a biotechnology and regenerative biomaterials company.